|
ABEO
|
Abeona Therapeutics Inc.
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
US
|
NASDAQ
|
|
CBIO
|
Catalyst Inc.
|
US
|
NASDAQ
|
|
CLGN
|
CollPlant Holdings, Ltd.
|
US
|
NASDAQ
|
|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ELOX
|
Eloxx Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ENZ
|
Enzo Biochem, Inc.
|
US
|
NYSE
|
|
FDMT
|
4D Molecular Therapeutics, Inc.
|
US
|
NASDAQ
|
|
FIXX
|
Homology Medicines, Inc.
|
US
|
NASDAQ
|
|
FRLN
|
Freeline Therapeutics Holdings plc
|
US
|
NASDAQ
|
|
GBIO
|
Generation Bio Co.
|
US
|
NASDAQ
|
|
GRPH
|
Graphite Bio, Inc.
|
US
|
NASDAQ
|
|
GTH
|
Genetron Holdings Limited
|
US
|
NASDAQ
|
|
HBIO
|
Harvard Bioscience, Inc.
|
US
|
NASDAQ
|
|
HELX
|
Franklin Genomic Advancements ETF
|
US
|
AMEX
|
|
ILMN
|
Illumina, Inc.
|
US
|
NASDAQ
|
|
INZY
|
Inozyme Pharma, Inc.
|
US
|
NASDAQ
|
|
LMNL
|
Liminal BioSciences Inc.
|
US
|
NASDAQ
|
|
LOCL
|
Local Bounti Corporation
|
US
|
NYSE
|